Retrospective Review of 190 Patients Treated for Parotid Tumors: A Single Institute Experience
Li Jing-jia,Zhang Ge-hua,Liu Xian,Ye Jin,Yang Qin-tai,Huang Jian-cong,Wu Si,Yin Gen-di
DOI: https://doi.org/10.3760/cma.j.issn.0366-6999.20122528
IF: 6.133
2013-01-01
Chinese Medical Journal
Abstract:Salivary gland neoplasms account for 3%-6% of all head and neck neoplasms, and the incidence was estimated to range from 0.4 to 13.5 cases per 100 000 inhabitants annually. Histologically, salivary gland tumors are a diverse group of neoplasms, making it difficult to establish a common standard for diagnosis and treatment. Most of the current studies concerning salivary gland tumors investigated the histological features and clinical manifestations including both major and minor salivary gland tumors, making it difficult to evaluate their real frequency and site distribution. Parotid tumor is the most frequently occurring salivary neoplasms, comprising 60%-80% of all salivary gland tumors. Clinical experience led us to suspect that our epidemiology of parotid tumors in south China may be different from that of other areas in the world. Here, we retrospectively reviewed parotid tumor cases and aimed to summarize the clinical presentation, histological feature, and surgical complications of parotid tumors. METHODS One hundred and ninety patients who were diagnosed as parotid tumor and underwent parotidectomy at the Department of Otolaryngology, Head and Neck Surgery, the Third Affiliated Hospital of Sun Yat-sen University between September 2005 and August 2011 were studied retrospectively. Patients were treated by the same surgeon group, and surgical strategy was determined by the preoperative and perioperative findings: benign parotid tumors located in the superficial lobe were treated by superficial parotidectomy, and benign tumors in the deep lobe by total parotidectomy; in patients with suspected malignant lesions, perioperative frozen section was performed, and the final surgical strategy depended on the tumor stage and histological grade. Tumor histological type was categorized according to the 2005 WHO classification criteria. Information about the age, gender, tumor size, past history, surgical method, and complications were collected from the medical records. The SPSS16.0 software package (SPSS, Inc., Chicago, IL, USA) was used for statistics. Two sample t-test was used to compare the differences in age between subgroups, and χ2 test was used to assess the differences in other parameters. P <0.05 was considered to be statistically significant. RESULTS One hundred and ninety patients served as the subjects for this study, including 118 male and 72 female with an average age of 43.6 years. Of the 190 patients, 159 (83.7%) were benign, 26 (13.7%) were malignant, and five were chronic inflammatory disease; the benign-to-malignant ratio was 6.1:1.0. Pleomorphic adenoma was the most common benign tumor, it accounted for 56.6% (90/159) of the benign tumors. The second commonest benign tumor was Warthin's tumor (23.3%, 37/159). Basal cell adenoma (7.5%, 12/159), lymphoepithelial cyst (6.9%, 11/159), oncocytoma (2.5%, 4/159), myoepithelioma (1.3%, 2/159), cystadenoma (1.3%, 2/159), and intraductal papilloma (0.6%, 1/159) were uncommon benign parotid tumors. Of the 26 malignancies, mucoepidermoid carcinoma (30.8%, 8/26) was the most common histological type, followed by lymphoma (15.4%, 4/26), carcinoma ex pleomorphic adenoma (15.4%, 4/26), acinic cell carcinoma (11.5%, 3/26), squamous cell carcinoma (11.5%, 3/26), and adenoid cystic carcinoma (7.7%, 2/26). Adenocarcinoma (3.8%, 1/26) and basal cell carcinoma (3.8%, 1/26) were rare. Most benign tumors occurred among patients aged 30-59 years (63.5%, 101/159), and the peak decade of incidence was the fourth decade of life (Figure 1); most malignant tumors occurred among patients aged 40-59 years (50.0%, 13/26), and the peak decade of incidence was the fifth decade of life. Both benign and malignant tumors presented a slight propensity towards male; the male to female ratio was 1.6:1.0 in benign tumors and 2.3:1 in malignant tumors (Table 1). Four cases had bilateral lesions in benign tumors, while no bilateral lesion was found in malignant tumors. Among benign tumors, most lesions were located in the superficial lobe; only 33 tumors (20.8%, 33/159) were located in the deep lobe, while among malignant tumors, 12 (46.2%, 12/26) were located in the deep lobe, which was significantly higher than benign tumors (P=0.005). Tumors with maximal diameter between 2 cm and 4 cm comprised the majority of cases both in the benign and malignant groups, and there were no significant differences in tumor diameter between benign tumors and malignant tumors.Figure 1.: Age distribution of benign and malignant parotid tumors.Table 1: Comparison of benign and malignant parotid tumorsWe compared the clinicopathological features of pleomorphic adenoma and Warthin's tumor; there were statistically significant differences in age, gender, bilateral lesion, and smoking history between the two groups (Table 2). The average age of patients with Warthin's tumor was 57 years, which was significantly older than patients with pleomorphic adenoma. Most pleomorphic adenoma occurred among patients aged 30-49 years; the peak decade of incidence was the fourth decade of life (Figure 2). Most Warthin's tumor occurred among patients aged 50-69 years; the peak decade of incidence was the sixth decade of life. Warthin's tumor had a strong male predominance. Bilateral lesion was more common in Warthin's tumor, 4 of 37 patients presented with bilateral tumors, but no bilateral tumor was found in pleomorphic adenoma. Of the patients with Warthin's tumor, 15 were smokers, the proportion was significantly higher than in patients with pleomorphic adenoma. There were no differences in tumor location, diameter, and recurrence rate.Table 2: Comparison of pleomorphic adenoma and Warthin's tumorFigure 2.: Age distribution of pleomorphic adenoma and Warthin's tumor.With regard to postoperative complications, 32 patients presented with transient facial paresis, most of which was categorized as House-Brackman grade I/II, and the marginal mandibular branch was most frequently involved. Ten patients presented with permanent facial paralysis for more than 6 months; eight of the 10 had malignant tumors. Other complications included Frey syndrome (3.2%), seroma (1.6%), hematoma (2.2%), and wound infection (1.1%). There were two patients who presented with coexisting double complications, one with coexisting transient facial paresis and Frey syndrome and the other with coexisting hematoma and wound infection. DISCUSSION Parotid gland tumors are relatively rare neoplasms in the head and neck region; they represent one of the most heterogeneous groups of tumors with great histological diversity. The patient age, sex distribution, and histological type of parotid tumors vary with race and geographic areas. Compared to pleomorphic adenoma, Warthin's tumor presented with some distinctive features. Warthin's tumor was prevalent in older patients while pleomorphic adenoma was more prevalent in the middle-aged patients. The male to female ratio was 8.3:1.0 in Warthin's tumor, which was comparable to that reported by Tian et al1 It seems that Warthin's tumor exhibited increasing incidence in ethnic Chinese populations, but the exact reason is still unknown. Genetic factors may play a role; smoking is another etiological factor responsible for the high incidence.1 Epstein-Barr virus (EBV) infection, which is prevalent in south China and southeast Asia, might be involved in the etiology of Warthin's tumor. Some studies proved the existence of EBV in Warthin's tumor,2 but more recent studies failed to show the relationship between EBV infection and Warthin's tumor.3 In our study, benign parotid tumors were treated by partial parotidectomy with preservation of the facial nerve. Although there were reports suggesting that limited excision like enucleation or limited superficial parotidectomy could be performed in elderly patients with multiple comorbidities, these methods were not recommended in our hospital. Currently, there is controversy in the management of Warthin's tumor. The surgical approach to Warthin's tumor has been recommended for many years. Nevertheless, there is still no unified opinion on the most appropriate surgical strategy. Superficial parotidectomy is the most common treatment modality due to the low recurrence rate. However, some surgeons preferred enucleation and local excision to superficial parotidectomy because of the low recurrence rate and facial nerve injury in their studies.7 Since Warthin's tumor exhibits the feature of low rate of growth and malignant transformation, preoperative examinations such as dynamic contrast-enhanced or diffusion-weighted magnetic resonance images and fine-needle aspiration cytology could provide sufficient information for the diagnosis of Warthin's tumor. Conservative treatment, which does not bring about surgical complications, has been advocated for treating these patients. Yet, there are few patients who have been treated nonsurgically, and the prognosis in nonsurgically treated patients is unclear; it is difficult to compare conservative treatment with traditional surgery. In our study, 32 patients presented with transient facial paresis, 10 patients with permanent facial paralysis for more than 6 months; most of them had malignant tumors. There are several factors responsible for the transient facial nerve paresis: superficial or total parotidectomy inevitably involved in the procedure of identification and dissection of facial nerve, possibly leading to the swelling of branches of the facial nerve and temporary neurologic impairment. Domenick and Johnson5 proved that parotid tumor diameter was both a convenient and functional means of predicting proximity of a tumor to the facial nerve; tumors with diameter ≥5 cm were more likely to have a positive facial nerve margin. Postoperative compressive dressing with elastic bandage tape, which was used to prevent complications of hematoma and seroma, resulted in the compression of the surgically exposed facial nerve, and increased the possibility of transient facial nerve paresis. Permanent facial nerve paralysis is prevalent in malignant parotid tumors. Owing to the malignant feature of infiltrating growth and extraparenchymal extension, facial nerve is more likely to be invaded by malignancies. Peeling the tumor off the facial nerve cannot achieve radical excision because of the insufficient surgical margin, so part or all of the facial nerve has to be sacrificed during operation. Although there are several methods of nerve reconstruction, permanent facial nerve paralysis remains a problem in the management of malignant parotid tumors.